• Vk
  • LinkedIn
  • Youtube
X7 Research
  • News
  • Registration strategy and Сonsulting
    • Budgeting
    • Registration strategy development
    • Study feasibility
    • Vendor selection
    • Data search and analysis
  • Clinical trials
    • Outsourcing CRAs in Russia and the EAEU
    • Development of medical documentation and biostatistics
    • Monitoring
    • Data-management
    • Patient home visits
    • Bioequivalence study
    • Therapeutic equivalence studies
    • Clinical trials of medical devices
  • Registration
    • Audit of the registration dossier
    • Bringing the registration dossier in compliance with the requirements of the EAEU
    • Conversion of registration dossier into XML format
    • PIL readability user testing
    • Translation of the Registration dossier
    • Turnkey registration
  • Post-authorization clinical studies
    • Phase IV studies
    • Non-interventional studies
    • Investigator-initiated studies
    • Post-authorisation safety study
    • Marketing research
  • Pharmacovigilance
    • QPPV in the EAEU
    • Safety monitoring of medical devices
    • Building a pharmacovigilance system
    • Safety in clinical trials
    • Pharmacovigilance audit
    • Pharmacovigilance contact person
  • Therapeutic expertise
    • Clinical trials in Oncology in the EAEU
  • Contact
  • EnglishEnglish
  • Menu

What is bioequivalence

11.12.2017/in News /by Evgenii Tkachenko

It is known that a lot of the drugs sold in Russia are not original drugs, but their reproducible counterparts, which is due to much lower costs for the organization of production and market entry in comparison with the original, new drugs. Big pharmaceutical companies are investing heavily in the development of new medicines. This is one of the main reasons for the high price of drugs. However, there are companies that specialize in the generics production. Generics are more accessible to different segments of the population, due to the fact that the cost of developing the drug and its broad clinical studies are not included in their price. However, in this case, generics must accord the same standards of quality, efficacy, and safety as are required for original medicines. To comply with all the above standards, it is necessary to conduct a bioequivalence study.

There are the following types of equivalence:

  • pharmaceutical,
  • pharmacokinetic (bioequivalence),
  • therapeutic.

The focus of this article is the bioequivalence study. Bioequivalence is the degree of similarity of a pharmaceutically equivalent drug to a reference drug (usually a generic to an original drug). It is determined experimentally, in vivo. The main criteria for bioequivalence are:

  • the degree and rate of the drug absorption,
  • time to reach the maximum concentration in the blood and its value,
  • the nature of drug distribution in tissues and body fluids,
  • type and rate of the drug withdrawal.

Sometimes the concepts of bioequivalence and bioavailability are confused, so it is worthwhile to clearly distinguish between these terms. Bioavailability is a subcategory of absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. According to the definition of WHO, two drugs are considered bioequivalent, if they are pharmaceutically equivalent, have the same bioavailability and when used in the same dose ensure proper efficacy and safety.

In the most compressed form, this information is sufficient to understand what bioequivalence is, why it is needed, and what parameters of drugs are taken into account when comparing drugs. However, for a deeper understanding of this topic, it is necessary to answer several other questions, such as: on the basis of what mathematical and statistical conclusions is the decision about the bioequivalence of drugs taken? Who participates in such trial? Who is the object of such trial? What basic documents are needed to conduct such trial? What methods are used in these studies? Finally, who conducts such studies? On these and on many more questions you can find answers in our next articles.

X7 Research is familiar not only with terminology but also with the practice of bioequivalence. Our team answers all the questions posed in the shortest time. Entrust your project to our professional team, to the company that is known in the industry for consistently high-quality work and reliability.

Source: pharmacokinetica.

Tags: bioequivalence
Share this entry
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
You might also like
Importance of bioavailability in the bioequivalence

YOU MAY ALSO BE INTERESTED IN

Publications
Readability User Testing of Package Information Leaflets (PIL) in EAEU
Read More
Publications
Remote clinical trial monitoring
Read More
Publications
Post-authorization studies of drug safety in Russia
Read More

RUBRICS

Registration strategy and Сonsulting

Clinical trials

Registration

Post-authorization clinical studies

Pharmacovigilance

LATEST PUBLICATIONS

  • Corrections to clinical trial documents due to COVID-19. Russian experience.
  • WHAT IS BIOEQUIVALENCE
  • THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019

Tags

bioequivalenceClinical trials in the CISfeasibilitymonitoringRadiopharmaceuticals

CONTACT

0 + 2 = ?

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

PRIVACY

Use of this site constitutes your consent to our Privacy Policy.


SOCIAL RESPONSIBILITY

X7 Research’s primary responsibility is to help our clients in bringing medicines & products to the market efficiently and safely.

The Best CRO for Clinical Trials | Full-service Global CRO — X7 Research

The Best CRO in Pharma | Clinical Research Organisation — X7 Research

The Best Contract Research Organisation (CRO) | Trusted CRO — X7 Research

The Best Clinical Research Organisation (CRO): Full Service CRO | X7 Research

The Best CRO in Research | Trusted CRO for Your Trail — X7 Research

The Best Clinical Trial Company | Global Full-service CRO - X7 Research

The Best Pharma CROs: Clinical Trials for Drugs | X7 Research

The Best CROs Company: Clinical Trials with Global CRO — X7 Research

The Best Pre-clinical CRO: Safety Assessment With X7 Research

The Best Clinical Development | Trusted CRO for Your Product: X7 Research

The Best Biostatistical Consulting: Statistical Services | X7 Research

The Best Pharmacovigilance Consulting Services | CRO — X7 Research

Feasibility in Clinical Trials: What is a Feasibility in Clinical Trials?

Clinical Study Trials: What are Clinical Study Trials?

Category
Strategy and consulting
Clinical trials
Registration
Post-authorization clinical studies
Pharmacovigilance

Registration strategy and Сonsulting
Registration strategy development
Budgeting
Study feasibility
Vendor selection
Data search and analysis

Clinical trials
Development of medical documentation and biostatistics
Monitoring
Data management
Patient home visits
Bioequivalence study
Therapeutic equivalence studies

Registration
Audit of the registration dossier
Dossier eaeu
Conversion of registration dossier into xml format
Pil readability user testing
Turnkey registration

Post-authorization clinical studies
Phase iv studies
Non interventional studies
Investigator initiated studies
Post authorisation safety study
Marketing research

Pharmacovigilance
Building a pharmacovigilance system
Safety in clinical trials
Pharmacovigilance audit
Pharmacovigilance contact person

Blog
Contacts

© Copyright 2010-2023 - X7 Research. All rights reserved.
Pharmacovigilance system audit X7 Research Pharmacovigilance service
Scroll to top